<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39360262</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Diagnostics for detection and surveillance of priority epidemic-prone diseases in Africa: an assessment of testing capacity and laboratory strengthening needs.</ArticleTitle><Pagination><StartPage>1438334</StartPage><MedlinePgn>1438334</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1438334</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1438334</ELocationID><Abstract><AbstractText>In 2023, Africa experienced 180 public health emergencies, of which 90% were infectious diseases and 75% were related to zoonotic diseases. Testing capacity for epidemic-prone diseases is essential to enable rapid and accurate identification of causative agents, and for action to prevent disease spread. Moreover, testing is pivotal in monitoring disease transmission, evaluating public health interventions and informing targeted resource allocation during outbreaks. An online, self-assessment survey was conducted in African Union Member States to identify major challenges in testing for epidemic-prone diseases. The survey assessed current capacity for diagnosing priority epidemic-prone diseases at different laboratory levels. It explored challenges in establishing and maintaining testing capacity to improve outbreak response and mitigate public health impact. Survey data analysed diagnostic capacity for priority infectious diseases, diagnostic technologies in use, existing surveillance programmes and challenges limiting diagnostic capacity, by country. The survey result from 15 Member States who responded to the survey, showed high variability in testing capacity and technologies across countries and diverse factors limiting testing capacity for certain priority diseases like dengue and Crimean-Congo haemorrhagic fever. At the same time diagnostic capacity is better for coronavirus disease 2019 (COVID-19), polio, and measles due to previous investments. Unfortunately, many countries are not utilizing multiplex testing, despite its potential to improve diagnostic access. The challenges of limited laboratory capacity for testing future outbreaks are indeed significant. Recent disease outbreaks in Africa have underscored the urgent need to strengthen diagnostic capacity and introduce cost-effective technologies. Small sample sizes and differing disease prioritisation within each country limited the analysis. These findings suggest the benefits of evaluating laboratory testing capacity for epidemic-prone diseases and highlight the importance of effectively addressing challenges to detect diseases and prevent future pandemics.</AbstractText><CopyrightInformation>Copyright © 2024 Ashenafi, Sule, Peter, Mashate, Otieno, Kebede, Oio, Kao, Carter, Whistler, Ndlovu and Kebede.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashenafi</LastName><ForeName>Aytenew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre of Laboratory Systems Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sule</LastName><ForeName>Olajumoke</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>International Health Regulations Strengthening Project, Health Protection Operations, United Kingdom Health Security Agency, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peter</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinton Health Access Initiative, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mashate</LastName><ForeName>Silver</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>African Society for Laboratory Medicine, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otieno</LastName><ForeName>Osborn</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Technical Advice and Partnerships Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kebede</LastName><ForeName>Abebaw</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre of Laboratory Systems Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oio</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre of Laboratory Systems Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Kekeletso</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Diagnostic System Strengthening Unit, FIND, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical and Diagnostics Programme, Amref Health Africa, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whistler</LastName><ForeName>Toni</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Technical Advice and Partnerships Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndlovu</LastName><ForeName>Nqobile</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>African Society for Laboratory Medicine, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kebede</LastName><ForeName>Yenew</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre of Laboratory Systems Division, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007753" MajorTopicYN="N">Laboratories</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cost-effective diagnostic technologies</Keyword><Keyword MajorTopicYN="N">epidemic-prone diseases</Keyword><Keyword MajorTopicYN="N">laboratory testing capacity</Keyword><Keyword MajorTopicYN="N">outbreak response</Keyword><Keyword MajorTopicYN="N">public health emergencies</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39360262</ArticleId><ArticleId IdType="pmc">PMC11445050</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1438334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Economic Forum . Building resilient healthcare systems in Africa with a focus on outbreaks and epidemics (2023). Available at: https://www.weforum.org/agenda/2023/07/building-resilient-healthcare-systems-in-africa-with-a-focus-on-outbreaks-and-epidemics/ (Accessed February 5-12, 2024).</Citation></Reference><Reference><Citation>Moyo E, Mhango M, Moyo P, Dzinamarira T, Chitungo I, Murewanhema G. Emerging infectious disease outbreaks in sub-Saharan Africa: learning from the past and present to be better prepared for future outbreaks. Front Public Health. (2023) 11:1049986. doi: 10.3389/fpubh.2023.1049986</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1049986</ArticleId><ArticleId IdType="pmc">PMC10203177</ArticleId><ArticleId IdType="pubmed">37228735</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa Centres for Disease Control and Prevention . Building testing capacity for epidemic-prone diseases (2023). Available at: https://africacdc.org/download/building-testing-capacity-for-epidemic-prone-diseases (Accessed February 5-12, 2024).</Citation></Reference><Reference><Citation>Africa Centres for Disease Control and Prevention . Disease outbreaks: information on disease outbreaks from Africa CDC (2023). Available at: https://africacdc.org/disease-outbreak/ (Accessed February 5-12, 2024).</Citation></Reference><Reference><Citation>Hayman DTS, Barraclough RK, Muglia LJ, McGovern V, Afolabi MO, N'Jai AU, et al. . Addressing the challenges of implementing evidence-based prioritisation in global health. BMJ Glob Health. (2023) 8:e012450. doi: 10.1136/bmjgh-2023-012450, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012450</ArticleId><ArticleId IdType="pmc">PMC10255200</ArticleId><ArticleId IdType="pubmed">37290897</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebisi YA, Rabe A, Lucero-Prisno DE, III. COVID-19 surveillance systems in African countries. Health Promot Perspect. (2021) 11:382–92. doi: 10.34172/hpp.2021.49, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/hpp.2021.49</ArticleId><ArticleId IdType="pmc">PMC8767077</ArticleId><ArticleId IdType="pubmed">35079582</ArticleId></ArticleIdList></Reference><Reference><Citation>Aborode AT, Hasan MM, Jain S, Okereke M, Adedeji OJ, Karra-Aly A, et al. . Impact of poor disease surveillance system on COVID-19 response in Africa: time to rethink and rebuilt. Clin Epidemiol Glob Health. (2021) 12:100841. doi: 10.1016/j.cegh.2021.100841, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2021.100841</ArticleId><ArticleId IdType="pmc">PMC8330137</ArticleId><ArticleId IdType="pubmed">34368503</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa Centres for Disease Control and Prevention . Risk ranking and prioritization of epidemic-prone diseases (2023). Available at: https://africacdc.org/download/risk-ranking-and-prioritization-of-epidemic-prone-diseases/ (Accessed February 5-12, 2024).</Citation></Reference><Reference><Citation>Nachega JB, Nsanzimana S, Rawat A, Wilson LA, Rosenthal PJ, Siedner MJ, et al. . Advancing detection and response capacities for emerging and re-emerging pathogens in Africa. Lancet Infect Dis. (2023) 23:e185–9. doi: 10.1016/S1473-3099(22)00723-X, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00723-X</ArticleId><ArticleId IdType="pmc">PMC10023168</ArticleId><ArticleId IdType="pubmed">36563700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewert B, Wallenburg I, Winblad U, Bal R. Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times. Health Econ Policy Law. (2023) 18:66–81. doi: 10.1017/S1744133122000238, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1744133122000238</ArticleId><ArticleId IdType="pubmed">36121039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajapaksha R, Khatri RB, Abeysena C, Wijesinghe MSD, Endalamaw A, Thomas TK, et al. . Success and challenges of health systems resilience-enhancing strategies for managing public health emergencies of international concerns (PHEIC): a systematic review protocol. BMJ Open. (2022) 12:e067829. doi: 10.1136/bmjopen-2022-067829, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067829</ArticleId><ArticleId IdType="pmc">PMC9680175</ArticleId><ArticleId IdType="pubmed">36410836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, et al. eds. Disease control priorities: Improving health and reducing poverty. Washington (DC): The World Bank; (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">30212058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyaruaba R, Okoye CO, Akan OD, Mwaliko C, Ebido CC, Ayoola A, et al. . Socio-economic impacts of emerging infectious diseases in Africa. Infect Dis (Lond). (2022) 54:315–24. doi: 10.1080/23744235.2021.2022195, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.2022195</ArticleId><ArticleId IdType="pubmed">35007473</ArticleId></ArticleIdList></Reference><Reference><Citation>Craven M, Sabow A, Van der Veken L, Wilson M. Not the last pandemic: investing now to reimagine public-health systems (2021). Available at: https://www.mckinsey.com/industries/public-sector/our-insights/not-the-last-pandemic-investing-now-to-reimagine-public-health-systems</Citation></Reference><Reference><Citation>Balogun OO, Akande OW, Hamer DH. Lassa fever: an evolving emergency in West Africa. Am J Trop Med Hyg. (2020) 104:466–73. doi: 10.4269/ajtmh.20-0487, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0487</ArticleId><ArticleId IdType="pmc">PMC7866331</ArticleId><ArticleId IdType="pubmed">33236712</ArticleId></ArticleIdList></Reference><Reference><Citation>Brehm B. The case for investment: insights from five African manufacturers on local manufacturing of diagnostic tools2023. Available at: https://www.path.org/our-impact/articles/investment-insights-local-manufacturing-diagnostic/ (Accessed February 5-12, 2024).</Citation></Reference><Reference><Citation>The Global Fund . Results report 2023. Geneva, Switzerland: The Global Fund; (2023).</Citation></Reference><Reference><Citation>Ramos PIP, Marcilio I, Bento AI, Penna GO, de Oliveira JF, Khouri R, et al. . Combining digital and molecular approaches using health and alternate data sources in a next-generation surveillance system for anticipating outbreaks of pandemic potential. JMIR Public Health Surveill. (2024) 10:e47673. doi: 10.2196/47673, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/47673</ArticleId><ArticleId IdType="pmc">PMC10806444</ArticleId><ArticleId IdType="pubmed">38194263</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderaro A, Piccolo G, Chezzi C. The laboratory diagnosis of malaria: a focus on the diagnostic assays in non-endemic areas. Int J Mol Sci. (2024) 25:695. doi: 10.3390/ijms25020695, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25020695</ArticleId><ArticleId IdType="pmc">PMC10815132</ArticleId><ArticleId IdType="pubmed">38255768</ArticleId></ArticleIdList></Reference><Reference><Citation>African Society for Microbiology . Bringing diagnostic testing closer to communities. Lab Culture (2022). Available at: https://aslm.org/wp-content/uploads/2022/06/ASLM_Lab_Culture_Issue_27.pdf</Citation></Reference><Reference><Citation>Kobia F, Gitaka J. COVID-19: are Africa's diagnostic challenges blunting response effectiveness? AAS Open Res. (2020) 3:4. doi: 10.12688/aasopenres.13061.1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/aasopenres.13061.1</ArticleId><ArticleId IdType="pmc">PMC7205356</ArticleId><ArticleId IdType="pubmed">32399515</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidt B, Siqueira WF, Eersels K, Diliën H, van Grinsven B, Fujiwara RT, et al. . Point of care diagnostics in resource-limited settings: a review of the present and future of PoC in its most needed environment. Biosensors (Basel). (2020) 10:133. doi: 10.3390/bios10100133, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bios10100133</ArticleId><ArticleId IdType="pmc">PMC7598644</ArticleId><ArticleId IdType="pubmed">32987809</ArticleId></ArticleIdList></Reference><Reference><Citation>Mfuh KO, Abanda NN, Titanji BK. Strengthening diagnostic capacity in Africa as a key pillar of public health and pandemic preparedness. PLOS Glob Public Health. (2023) 3:e0001998. doi: 10.1371/journal.pgph.0001998, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0001998</ArticleId><ArticleId IdType="pmc">PMC10263319</ArticleId><ArticleId IdType="pubmed">37310963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanda-Kapata P, Ntoumi F, Kapata N, Lungu P, Mucheleng'anga LA, Chakaya J, et al. . Tuberculosis, HIV/AIDS and malaria health services in sub-Saharan Africa - a situation analysis of the disruptions and impact of the COVID-19 pandemic. Int J Infect Dis. (2022) 124:S41–s6. doi: 10.1016/j.ijid.2022.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8949686</ArticleId><ArticleId IdType="pubmed">35341998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>